Some individuals find that weight loss or blood sugar improvements plateau on one medication, prompting interest in the alternative
The rationale is that weight loss beyond 15% often produces clinically meaningful improvements in joint symptoms, and retatrutide consistently crosses that threshold at moderate doses
This is the same whether you're starting treatment for the first time, restarting after a break from Mounjaro, or switching from another weight loss injection
Melson E, Miras AD, Papamargaritis D
The science behind Mounjaro Mounjaros active ingredient is tirzepatide, which mimics GLP-1 and GIP two hormones naturally found in your intestines
Most gastrointestinal side effects are classified as mild to moderate in severity and tend to occur primarily during dose escalation periods